The palliative care research community has been waiting for an internationally validated palliative care-specific health-related quality of life (HRQOL) instrument and the recently published EORTC QLQ-C15-PAL seems to be an important step forward in this direction. Although HRQOL is considered to be the most important outcome measure in palliative care, adequate instruments utilizable in the end-stage of disease are still lacking. Kaasa and Loge 1 emphasized the importance of this issue, and highlighted the fact that an authoritative HRQOL instrument for palliative care is not yet available. We therefore welcome the publication of the paper by Groenvold et al., 2 who presented a shortened version of the widely-used EORTC QLQ-C30 3 cancer-specific health-related quality of life questionnaire to be used in a palliative care setting. The latest version of the QLQ-C30 consists of 30 items comprising five multi-item scales (physical, role, emotional, cognitive, and social function), three symptom scales (fatigue, pain, and nausea/vomiting), one scale assessing 'global health status and quality of life', and six single items. By careful reduction of the number of QLQ-C30-items, the authors aimed at addressing the problems that make the QLQ-C30 unsuitable for use in palliative care settings: length and inappropriate or irrelevant content for patients receiving palliative care. The authors used two methods for reducing the number of QLQ-C30 items. Multi-item scales were reduced by means of techniques based on item response theory (IRT), a framework for analyzing multi-item scales, which is currently the most widely used method in computerized adaptive testing. 4 In a second stage, which was reported in the current article, 2 QLQ-C30 items were reduced by asking a group of patients and professional carers to rate the relevance and appropriateness of each. The authors used both methods for the construction of the QLQ-C15 PAL, and concluded that this new questionnaire ' . . . has good content validity as a ''core palliative care questionnaire'' assessing the symptoms and problems for which patients are frequently treated.' In addition, thanks to the use of IRT, the QLQ-C15-PAL makes the extension of cancer clinical trials possible to measurements of patients receiving palliative care. We believe the QLQ-C15-PAL will prove to be invaluable for researchers conducting clinical trials using the QLQ-C30, and who would like to follow-up their patients into the palliative care phase.
However, we believe that the QLQ-C15-PAL in its present form still has a number of limitations, which makes it hard to recommend as a 'core palliative care questionnaire'. We have concerns regarding sensitivity and the lack of relevant items.
Knobel et al. 5 found floor and ceiling effects of the fatigue subscale of the QLQ-C30 in comparison with a palliative care-specific fatigue measure. In addition, they questioned the validity of the QLQ-C30 fatigue subscale in palliative care settings. We wonder if the validity of other QLQ-C30/QLQ-C15-PAL subscales should also be questioned Á/ a legitimate concern, because the QLQ-C30 (of which 15 unaltered items appear in the QLQ-C15) was not developed for and validated in palliative care populations. 3 Thus, sensitivity and aspects of validity of the QLQ-C15-PAL should additionally be studied in cancer patients receiving palliative care.
We question the choice of asking a small group of selected patients about the relevance of items. It is very difficult for individuals to judge the relevance of problems that they did not experience before. It is not surprising, for example, that the patients in the Groenvold study did not believe that dyspnoea was particularly relevant to their quality of life, because the sample did not contain lung cancer patients. Similarly, it is not surprising that the relevance scores of patients and professionals (who witnessed the consequences of various symptoms for patients many times), diverged considerably (see Table 4 in the Groenvold paper). These differences do not justify averaging patient and professional relevance scores as was done is this study.
As was indicated by the respondents in the Groenvold study, key questions are missing in the questionnaire, including existential and spiritual issues, worries related to relatives and to the future, and issues related to information, satisfaction with care, and social support. Others have highlighted the importance of these topics. Hearn and Higginson 6 and Cohen and colleagues 7 demonstrated the importance of gauging existential well-being especially in advanced cancer patients. Studies assessing individual quality of life in advanced cancer patients showed that these topics indeed are equally relevant to patients' quality of life as most physical symptoms. 8 Groenvold proposed to supplement the QLQ-C15-PAL with items or modules measuring the missing aspects, but if the QLQ-C15-PAL needs to be supplemented by modules, wouldn't it defy the purpose of shortening the QLQ-C30 in the first place? Groenvold and colleagues seem to suggest that these issues are not the items 'most relevant and important for palliative care', but are 'supplementary' items that 'address more specific issues relevant to a given study'. Both the literature and our clinical experience with advanced cancer patients highlight the importance of addressing existential and spiritual issues, worries about family, and social support as core issues in palliative care; they should not merely be consigned to a role of 'supplementary' or secondary importance.
It seems that it may have been preferable to draft a core palliative care-specific HRQOL instrument from the ground up, as did Mystakidou, 9 for example, who developed an instrument for Greece. We trust that methods including caretaker focus groups, sufficiently large patient groups with a broad variety of diagnoses and disease stages, or literature reviews will lead the investigators to include the mentioned aspects that are now missing from the QLQ-C15-PAL. Perhaps, instead of developing PAL modules, the EORTC quality of life group could use their infrastructure to develop a pool of relevant items for use with computerized adaptive testing. 4 This IRT-based technique is specifically appealing for research in advanced cancer patients, because it allows for very quick and tailored assessments that select the most appropriate items and the optimal test length for individual patients, while between-patient group comparisons based on relevant scales continues to be possible.
The development of QLQ-C15-PAL is welcome but it needs further refinement. For now, even though far from ideal, it seems better to manually select items and scales needed for a specific study from existing validated instruments (a view congruent with Kaasa and Loge 1 ) than to use the QLQ-C15-PAL. This practise at least guarantees that all relevant topics are represented, while administering the items to palliative care patients remains feasible. A usable, internationally validated HRQOL questionnaire containing relevant items for cancer patients receiving palliative care remains on our wish list.
